Anlon Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01025
  • NSEID: AHCL
  • BSEID: 544497
INR
25.14
0.2 (0.8%)
BSENSE

Nov 20

BSE+NSE Vol: 52.72 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
105.61
87.56
50.89
35.58
52.20
33.30
48.93
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
105.61
87.56
50.89
35.58
52.20
33.30
48.93
Raw Material Cost
48.69
73.04
52.78
26.10
40.83
29.59
27.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
24.19
-6.96
-24.93
-6.03
-7.87
-5.37
-0.28
Employee Cost
2.59
1.95
1.54
1.71
1.06
1.22
1.25
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
4.90
3.94
6.21
1.53
4.47
1.61
2.86
Total Expenditure (Excl Depreciation)
80.37
71.97
35.60
23.31
38.49
27.05
31.74
Operating Profit (PBDIT) excl Other Income
25.24
15.59
15.29
12.27
13.71
6.25
17.19
Other Income
0.05
0.06
0.01
0.20
0.03
0.01
0.04
Operating Profit (PBDIT)
25.29
15.65
15.30
12.47
13.74
6.26
17.23
Interest
0.86
0.92
0.57
1.51
0.84
0.82
0.91
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
24.43
14.73
14.73
10.96
12.90
5.44
16.32
Depreciation
0.95
1.07
0.29
0.35
0.45
0.43
0.83
Profit Before Tax
23.47
13.66
14.44
10.61
12.45
5.00
15.49
Tax
6.30
5.38
3.37
5.46
3.13
1.46
-1.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.18
8.28
11.07
5.15
9.32
3.55
16.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.18
8.28
11.07
5.15
9.32
3.55
16.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.81
1.62
0.57
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
13.37
6.66
10.50
5.15
9.32
3.55
16.65
Equity Capital
106.30
106.30
53.15
53.15
53.15
39.85
39.85
Face Value
2.0
2.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
0.25
0.13
0.2
0.1
0.18
0.09
0.42
Diluted Earnings per share
0.32
0.16
0.23
0.11
0.02
0.09
0.51
Operating Profit Margin (Excl OI)
23.9%
17.8%
30.05%
34.49%
26.26%
18.77%
35.13%
Gross Profit Margin
23.13%
16.82%
28.94%
30.8%
24.71%
16.34%
33.35%
PAT Margin
16.27%
9.46%
21.75%
14.47%
17.85%
10.66%
34.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 95.13% vs -44.10% in Jun 2026

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is 67.71% vs -50.97% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 93.71% vs -46.30% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -2.08% vs -18.64% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Anlon Healthcare With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
105.61
96.37
9.24
9.59%
Other Operating Income
0.00
0.00
0.00
Total Operating income
105.61
96.37
9.24
9.59%
Raw Material Cost
48.69
4.68
44.01
940.38%
Purchase of Finished goods
0.00
35.86
-35.86
-100.00%
(Increase) / Decrease In Stocks
24.19
0.43
23.76
5,525.58%
Employee Cost
2.59
23.33
-20.74
-88.90%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
4.90
15.18
-10.28
-67.72%
Total Expenditure (Excl Depreciation)
80.37
79.47
0.90
1.13%
Operating Profit (PBDIT) excl Other Income
25.24
16.90
8.34
49.35%
Other Income
0.05
2.25
-2.20
-97.78%
Operating Profit (PBDIT)
25.29
19.15
6.14
32.06%
Interest
0.86
0.29
0.57
196.55%
Exceptional Items
0.00
-0.24
0.24
100.00%
Gross Profit (PBDT)
24.43
18.62
5.81
31.20%
Depreciation
0.95
2.21
-1.26
-57.01%
Profit Before Tax
23.47
16.42
7.05
42.94%
Tax
6.30
4.13
2.17
52.54%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
17.18
12.29
4.89
39.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
17.18
12.29
4.89
39.79%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
3.81
0.00
3.81
Other related items
0.00
0.00
0.00
Consolidated Net Profit
13.37
12.29
1.08
8.79%
Equity Capital
106.30
13.21
93.09
704.69%
Face Value
2.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.25
1.86
-1.61
-86.56%
Diluted Earnings per share
0.32
1.83
-1.51
-82.51%
Operating Profit Margin (Excl OI)
23.90%
17.54%
0.00
6.36%
Gross Profit Margin
23.13%
19.32%
0.00
3.81%
PAT Margin
16.27%
12.75%
0.00
3.52%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 60.45 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 95.13% vs -44.10% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 15.80% vs 115.97% in Sep 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 8.05 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 67.71% vs -50.97% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -13.63% vs 259.85% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.47 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 93.71% vs -46.30% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 5.54% vs 82.31% in Sep 2025

Quarterly - Interest
Interest 0.94 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -2.08% vs -18.64% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 11.90% vs -9.68% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.94%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has fallen from Sep 2025